Emistop 4mg & 8 mg Injection (aqueous solution).
PDF Leaflet Revision Date: 16 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Management of nausea and vomiting induced by chemotherapy, radiotherapy, and post-operative.
Dosage (summary)
Adults: 8 mg IV/IM before treatment, then 8 mg orally every 12 hours.
Onset of Action / Duration
Onset: 30 mins, Duration: Up to 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in first 12 weeks of pregnancy; avoid breastfeeding.
Key Drug Interactions
- Apomorphine
- CYP3A4 inducers
- QT prolonging agents
Contraindications
- Hypersensitivity to ondansetron
- Pregnancy
- Congenital long QT syndrome
Common side effects
- Headache
- Dizziness
- Constipation
- Hypotension
Counselling Points
- Monitor for signs of QT prolongation.
- Avoid use in early pregnancy.
- Report any severe allergic reactions.
Serious warnings
- QT prolongation
- Myocardial ischemia
- Serotonin syndrome
Important Disclaimer
The Emistop 4mg & 8 mg Injection (aqueous solution). professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
